1 The Butajira Rural Health Project in Ethiopia: mothers' perceptions and practices in the care of children with acute respiratory infections

2 Persistent diarrhea in Vietnamese children: a preliminary report

3 Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses.

4 Central Nervous System Infections Due to Coccidioidomycosis.

5 Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

6 The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model

7 Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance.

8 Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections.

9 Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance

10 Community-associated Staphylococcus aureus PVL+ ST22 predominates in skin and soft tissue infections in Beijing, China

11 Antimicrobial susceptibility changes of Escherichia coli and Klebsiella pneumoniae intra-abdominal infection isolate-derived pathogens from Chinese intra-abdominal infections from 2011 to 2015

12 Evaluating the potential use of electronic tongue in early identification and diagnosis of bacterial infections

13 Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

14 An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017 [Corrigendum]

15 Chlorquinaldol, a topical agent for skin and wound infections: anti-biofilm activity and biofilm-related antimicrobial cross-resistance

16 Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [Letter]

17 Epidemiology and molecular characterization of mcr-1 in Escherichia coli recovered from patients with bloodstream infections in Changsha, central China

18 Community acquired urinary tract infections among adults in Accra, Ghana

19 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

20 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

21 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

22 Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials

23 Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections

24 Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

25 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

26 Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient

27 Molecular characterization, serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections

28 In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections

29 Treatment of late bacterial infections resulting from soft-tissue filler injections

30 Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections [Corrigendum]

31 Selection between aztreonam and cephalosporins for treatment of infections with pseudomonads needs more caution

32 Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints

33 Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

34 An increasing trend of neonatal invasive multidrug-resistant group B streptococcus infections in southern China, 2011–2017

35 Vancomycin in the treatment of adult intra-abdominal infections: do we have strong evidences?

36 A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

37 Health care-associated infections – an overview

38 A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese antimicrobial resistance surveillance of nosocomial infections (CARES) 2007–2016

39 Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners

40 Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality

41 Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections

42 Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics

43 Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

44 Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: in vitro and in vivo studies

45 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

46 Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections

47 Trichosporon dohaense, a rare pathogen of human invasive infections, and literature review

48 Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia

49 First molecular characterization of related cases of healthcare-associated infections involving multidrug-resistant Enterococcus faecium vanA in Algeria

50 Benchmarking for surgical site infections among gastrointestinal surgeries and related risk factors: multicenter study in Kuwait

51 Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey)

52 Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand

53 Clinical outcomes after initial treatment of methicillin-resistant Staphylococcus aureus infections

54 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

55 Current perspectives on diagnosis and management of sternal wound infections

56 Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan

57 Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations

58 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

59 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

60 Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study

61 A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality

62 Ambulance vehicles as a source of multidrug-resistant infections: a multicenter study in Assiut City, Egypt

63 Antibiotic sensitivities of coagulase-negative staphylococci and Staphylococcus aureus in hip and knee periprosthetic joint infections: does this differ if patients meet the International Consensus Meeting Criteria?

64 Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics

65 Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin

66 A systematic review and meta-analysis on the use of prophylactic topical antibiotics for the prevention of uncomplicated wound infections

67 Patient autonomy and disclosure of material information about hospital-acquired infections

68 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

69 Salmonella enterica serovars Typhimurium and Enteritidis causing mixed infections in febrile children in Mozambique

70 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

71 Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections

72 Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials

73 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

74 Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece

75 Mycoplasma genitalium infections: current treatment options and resistance issues

76 Cefazolin potency against methicillin-resistant Staphylococcus aureus: a microbiologic assessment in support of a novel drug delivery system for skin and skin structure infections [Erratum]

77 Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia

78 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

79 Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience

80 Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]

81 Strategies for prevention of ultrasound-guided prostate biopsy infections

82 Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

83 Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections

84 Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients

85 Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

86 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

87 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

88 Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria

89 Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections

90 Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs

91 Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management

92 Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections

93 Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates

94 Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections

95 The role of dolutegravir in the management of HIV infections

96 Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

97 Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections

98 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

99 Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden

100 Invasive Aspergillus infections in hospitalized patients with chronic lung disease

101 Clinical update on linezolid in the treatment of Gram-positive bacterial infections

Keyword Connections

Journals

Research Groups

Bibliographies